Marshall W. Fordyce
- Infectious Diseases top 1%
- Virology top 0.5%
- Emergency Medicine top 1%
- Epidemiology top 10%
- Hepatology top 5%
- Co-authors
- Tomáš CihlářAdrian S. RayMichael J. M. HitchcockChristian CallebautAndrew ChengLijie ZhongScott McCallisterEdwin DeJesus
- Topics
- HIV/AIDS drug development and treatment (25 papers)HIV Research and Treatment (18 papers)HIV-related health complications and treatments (14 papers)
- Journals
- Journal of the American Society of NephrologyAntimicrobial Agents and ChemotherapyQuality of Life Research
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Marshall W. Fordyce
30 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 1.5k
- Virology 955
- Emergency Medicine 500
- Epidemiology 443
- Hepatology 233
Countries citing papers authored by Marshall W. Fordyce
This map shows the geographic impact of Marshall W. Fordyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall W. Fordyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall W. Fordyce more than expected).
Fields of papers citing papers by Marshall W. Fordyce
This network shows the impact of papers produced by Marshall W. Fordyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall W. Fordyce. The network helps show where Marshall W. Fordyce may publish in the future.
Co-authorship network of co-authors of Marshall W. Fordyce
This figure shows the co-authorship network connecting the top 25 collaborators of Marshall W. Fordyce. A scholar is included among the top collaborators of Marshall W. Fordyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall W. Fordyce. Marshall W. Fordyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 19 | |
| 3 | 12 | |
| 4 | 145 | |
| 5 | 10 | |
| 6 | Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study | 12 |
| 7 | 230 | |
| 8 | 53 | |
| 9 | 9 | |
| 10 | 158 | |
| 11 | Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virusbreakdown → | 309 |
| 12 | 165 | |
| 13 | 21 | |
| 14 | 48 | |
| 15 | 247 | |
| 16 | 97 | |
| 17 | 64 | |
| 18 | 10 | |
| 19 | 6 | |
| 20 | 8 |
About Marshall W. Fordyce
Marshall W. Fordyce is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 30 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (18 papers) and HIV-related health complications and treatments (14 papers). The work is most often cited by research in Virology (955 citations), Infectious Diseases (1.5k citations) and Emergency Medicine (500 citations). Marshall W. Fordyce has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Tomáš Cihlář, Adrian S. Ray, Michael J. M. Hitchcock, Christian Callebaut, Andrew Cheng, Lijie Zhong, Scott McCallister, Edwin DeJesus, Frank A. Post and Michael E. Abram. Their work appears in journals such as Journal of the American Society of Nephrology, Antimicrobial Agents and Chemotherapy and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.